HALO
Halozyme Therapeutics, Inc. · Healthcare
Director James M Daly sold $875K of Halozyme Therapeutics, Inc.
Sold$874,520
$43.73Price
20,000Shares
−49%Stake
What HALO did after the filing
- The stock from Wed, Aug 16 open, $43.89
- −10.8%
- S&P 500, same days
- −2.8%
Measured over 30 trading days, to the Sep 28 close.
Traded Fri, Aug 11. Filed Tue, Aug 15, 4:04 PM ET, after the close. Returns use the Aug 16 open and the Sep 28 close. Not investment advice.